Atrial Fibrillation in Aging Heart: Role of Senescent Atrial Cells

衰老心脏中的心房颤动:衰老心房细胞的作用

基本信息

  • 批准号:
    10345318
  • 负责人:
  • 金额:
    $ 26.05万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-09-30 至 2024-05-31
  • 项目状态:
    已结题

项目摘要

The most common arrhythmia in the aging population is atrial fibrillation (AF), which carries an estimated lifetime risk of 25% after the age of 40 years. Cellular senescence is a stress response that is characterized by an irreversible loss of proliferative capacity, accompanied by a complex senescence-associated secretory phenotype (SASP) that can have profound effects on neighboring cells in the tissue. Our research plan is based on the following premises: Cellular senescence of atrial myocytes (AMs) and atrial cardiac fibroblasts (ACMFs) plays an important role in fibrosis, inflammation and arrhythmogenesis. The overarching hypothesis of our proposal is that atrial cell senescence is an important component of atrial aging and the increase incidence of AF. Specifically, we postulate that in the aging human (and rabbit) atrium, the interplay between aging and senescent AMs that have a lower threshold for arrhythmogenic activity and together with senescent ACMFs leads to fibrosis and the triggering of AF. This R21 proposal brings together several investigators with very different expertise to investigate mechanisms of AF in the aging heart, using a novel age-appropriate large animal model (rabbit), and human samples obtained from explanted hearts and right atrial appendage. In Aim 1 the Koren group will investigate the aging rabbit atria, as compared to the young atria, and correlate the arrhythmogenesis with molecular and cellular analysis of AMs and ACMFs. Senescence will be manipulated in vivo under Aim1 using pharmacologic approaches. Optical mapping of hearts ex vivo will be used to study arrhythmogenesis. In Aim 2 the group will study human explanted atria as well as tissue and AMs obtained from right atrial appendages during open heart surgery. In summary, we envision that by understanding the aging mechanisms that control cellular senescence we will be able to reduce fibrosis and the incidence of AF.
老年人口中最常见的心律失常是心房颤动(AF),据估计 40岁以后终生风险为25%。细胞衰老是一种应激反应,其特征是 不可逆转的增殖能力丧失,伴有复杂的衰老相关分泌 表型(SASP),可对组织中的邻近细胞产生深远影响。我们的研究计划是 基于以下前提:心房肌细胞(AM)和心房成纤维细胞的细胞衰老 (ACMFS)在纤维化、炎症和心律失常的发生中起重要作用。最重要的假设 我们的建议之一是,心房细胞衰老是心房衰老的重要组成部分,而 房颤的发生率。具体地说,我们假设在衰老的人(和兔)的心房中, 衰老和衰老的AM具有较低的致心律失常活动阈值,并伴有衰老 ACMFS导致纤维化和房颤的触发。这份R21提案将几名调查人员聚集在一起, 使用一种新的与年龄相适应的方法来研究老化心脏中房颤的机制 大动物模型(兔),以及取自移植心脏和右心耳的人类样本。在……里面 目的1韩国研究小组将研究老龄兔的心房,并与年轻的心房进行比较。 AM和ACMFS的分子和细胞分析与心律失常的发生。衰老将被操控在 Aim1下的活体使用药理学方法。体外心脏光学标测将用于研究 心律失常。在目标2中,研究小组将研究人类移植的心房以及获得的组织和AM 在心内直视手术中从右心耳。总而言之,我们设想通过理解 控制细胞衰老的衰老机制,我们将能够减少纤维化和房颤的发生率。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

GIDEON KOREN其他文献

GIDEON KOREN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('GIDEON KOREN', 18)}}的其他基金

Atrial Fibrillation in Aging Heart: Role of Senescent Atrial Cells
衰老心脏中的心房颤动:衰老心房细胞的作用
  • 批准号:
    10706970
  • 财政年份:
    2022
  • 资助金额:
    $ 26.05万
  • 项目类别:
Scarring and Arrhythmia in Infarcted Aged Hearts: Role of Senescent Fibroblasts
梗死老年心脏的疤痕和心律失常:衰老成纤维细胞的作用
  • 批准号:
    10335140
  • 财政年份:
    2019
  • 资助金额:
    $ 26.05万
  • 项目类别:
Cardiac ubiquitin ligases: regulation and role in modulating cardiac excitation.
心脏泛素连接酶:调节心脏兴奋的调节和作用。
  • 批准号:
    9974406
  • 财政年份:
    2017
  • 资助金额:
    $ 26.05万
  • 项目类别:
A Multi-Scale Approach to Cardiac Arrhythmia: from the Molecule to the Organ
治疗心律失常的多尺度方法:从分子到器官
  • 批准号:
    8411857
  • 财政年份:
    2013
  • 资助金额:
    $ 26.05万
  • 项目类别:
A Multi-Scale Approach to Cardiac Arrhythmia: from the Molecule to the Organ
治疗心律失常的多尺度方法:从分子到器官
  • 批准号:
    8708950
  • 财政年份:
    2013
  • 资助金额:
    $ 26.05万
  • 项目类别:
Sex Hormones and Cardiac Arrhythmia in Transgenic LQT2 Rabbits
转基因 LQT2 兔的性激素和心律失常
  • 批准号:
    8055499
  • 财政年份:
    2009
  • 资助金额:
    $ 26.05万
  • 项目类别:
Sex Hormones and Cardiac Arrhythmia in Transgenic LQT2 Rabbits
转基因 LQT2 兔的性激素和心律失常
  • 批准号:
    7789586
  • 财政年份:
    2009
  • 资助金额:
    $ 26.05万
  • 项目类别:
Sex Hormones and Cardiac Arrhythmia in Transgenic LQT2 Rabbits
转基因 LQT2 兔的性激素和心律失常
  • 批准号:
    7668883
  • 财政年份:
    2009
  • 资助金额:
    $ 26.05万
  • 项目类别:
Sex Hormones and Cardiac Arrhythmia in Transgenic LQT2 Rabbits
转基因 LQT2 兔的性激素和心律失常
  • 批准号:
    8242689
  • 财政年份:
    2009
  • 资助金额:
    $ 26.05万
  • 项目类别:
Brown CardioPulmonary Research Training Program
布朗心肺研究培训计划
  • 批准号:
    7905834
  • 财政年份:
    2008
  • 资助金额:
    $ 26.05万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 26.05万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 26.05万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 26.05万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 26.05万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 26.05万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 26.05万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 26.05万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 26.05万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 26.05万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 26.05万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了